Advanced Solid Tumour clinical trials

Explore recruiting advanced solid tumour clinical trials.

Recruiting advanced solid tumour studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Solid Tumour trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An open-label, phase I/II first-in-human, dose escalation and confirmation study to evaluate the safety, tolerability, pharmacokinetic, pharmacodynamic and anti-tumour activity of IPN01195 as single agent in adult participants with advanced solid tumours

Spain, France, Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A trial to learn how ceralasertib affects the way certain medications move throughout the body over time and how safe it is to use ceralasertib with these medications in adults with advanced solid tumors

Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Clinical Trial for Patients with Advanced Cancers

Spain, Italy, Romania, France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

An phase I study of BI 765063 (a monoclonal antibody) as single agent and in combination with BI 754091 (a PD-1) to characterize safety, pharmacokinetics, pharmacodynamics and preliminary efficacy in patients with advanced solid tumour

France

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Basket of Baskets: A Modular, Open-label, Phase II, Multicentre Study To Evaluate Targeted Agents in Molecularly Selected Populations With Advanced Solid Tumours

Sweden, Netherlands, Spain, Germany, France, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

MOVIE_A phase I/II basket trial evaluating a combination of Metronomic Oral Vinorelbine plus anti-PD-L1/anti-CTLA4 ImmunothErapy in patients with advanced solid tumours.

France

Phase I and Phase II (Integrated)- Bioequivalence Study EU CTIS Study details

Advanced Solid Tumour trials by city

Advanced Solid Tumour in Toronto Advanced Solid Tumour in Vancouver Advanced Solid Tumour in Montreal Advanced Solid Tumour in Calgary Advanced Solid Tumour in Edmonton Advanced Solid Tumour in Ottawa Advanced Solid Tumour in Winnipeg Advanced Solid Tumour in Quebec City Advanced Solid Tumour in Hamilton Advanced Solid Tumour in Kitchener Advanced Solid Tumour in London Advanced Solid Tumour in Halifax Advanced Solid Tumour in New York Advanced Solid Tumour in Los Angeles Advanced Solid Tumour in Chicago Advanced Solid Tumour in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease